Organization
Skin Centre for Dermatology and Probity Medical Research, Peterborough, Canada
1 abstract
Abstract
52-WEEK EFFICACY AND SAFETY OF APREMILAST AND SWITCH FROM ETANERCEPT IN PATIENTS WITH MODERATE TO SEVERE PSORIASIS: RESULTS FROM THE LIBERATE STUDY Org: SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany, Southern California Dermatology, Santa Ana, United States, Skin Centre for Dermatology and Probity Medical Research, Peterborough, Canada, Celgene Corporation, Summit,